Latest filing published 12 Jun 2026 for Arcus Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Carolyn C. Tang (board member) discloses dealings in Arcus Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 16 June 2021 to 11 June 2026, the count stands at 17 filings.
No open-market purchase appears, only 7 sales worth €301k. Besides market trades, the filings include 7 share grants and 1 option exercise.
The record was last updated on 12 June 2026 with an option exercise in Arcus Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations